# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001558370-24-008425
Filing Date
2024-05-17
Accepted
2024-05-17 17:05:17
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-17

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | plx-20231231xars.pdf | ARS | 1909554
| Complete submission text file | 0001558370-24-008425.txt |  | 2631297

Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33357 | Film No.: 24961170
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)